Salix announced that the FDA has approved Fulyzaq (crofelemer) delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy ...

The US Food and Drug Administration (FDA) today approved crofelemer (Fulyzaq, Salix Pharmaceuticals under license from Napo Pharmaceuticals, Inc) to relieve diarrhea in patients with HIV/AIDS who are ...

Advanced immunosuppression from HIV infection can lead to gastrointestinal symptoms such as diarrhea, nausea, vomiting, dysphagia, weight loss, and abdominal pain. There is a complex, combined effect ...

Early signs of HIV can include fatigue, rash, fever, chills, headache, sore throat, swollen lymph nodes, muscle aches, oral thrush, and night sweats. Some symptoms appear in the early stages of HIV, ...

More than half of people living with HIV experience chronic, or long-term, diarrhea that is serious enough to negatively impact their quality of life SAN FRANCISCO, CA / ACCESSWIRE / December 5, 2022 ...

Authors have cautioned that there is some variability observed by responder characteristics. The value of relative importance for weight gain was 0.16, which was slightly lower than 0.17, the value of ...

HIV is often surrounded by stigma, misinformation and silence. As a result, many people are unaware of the crucial symptoms that accompany it, leading to missed opportunities for early diagnosis and ...

So begins “Let’s Talk About (Surprise) Diarrhea,” an original song at the heart of Napo Pharmaceuticals’ “Surprise Diarrhea Lip-Syncing and Singing Contest,” launched Wednesday to mark National Gay ...